Bayer and Hologic have announced a collaboration to introduce a solution for contrast-enhanced mammography (CEM), a technique enhancing breast tissue visualization for improved breast cancer detection and treatment guidance. Contrast-enhanced mammography is a breast imaging modality aiding in breast cancer diagnosis. By integrating Hologic’s mammography technologies with Bayer’s contrast delivery system, the MEDRAD Stellant FLEX Computed Tomography (CT) Injection System, the collaboration…
Roche has achieved CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, a companion diagnostic designed to identify metastatic breast cancer patients expressing low levels of HER2. This approval enables the consideration of ENHERTU (trastuzumab deruxtecan) as a targeted treatment for these patients. Metastatic breast cancer (mBC) affects a significant portion of patients, with approximately half expressing low…
MOLLI Surgical, a company active in surgical innovation, has unveiled its latest breakthrough: OncoPen, a novel surgical tool designed to enhance precision and confidence in breast cancer surgery. The launch of OncoPen represents a significant advancement in minimally invasive surgery and promises improved outcomes for patients battling breast cancer. The OncoPen is seamlessly integrated with the MOLLI 2 System, providing surgeons with…
New promising advancements in breast cancer detection have been unveiled by scientists at Nottingham Trent University (NTU). The research team is pioneering the development of a revolutionary device designed to fit discreetly within a bra, offering potential breakthroughs in tumor monitoring. According to The Guardian, this innovative device promises to provide a non-invasive method for detecting tumor growth, empowering patients to monitor…
Fujifilm Healthcare Europe has introduced the AMULET SOPHINITY digital mammography system at the European Congress of Radiology 2024. The system is designed to offer high-resolution imaging while utilizing low-dose X-ray radiation, aimed at enhancing the accuracy and comfort of breast cancer diagnostics. Breast cancer is the leading cancer among women in Europe, and with cancer diagnoses expected to rise, the need for…
Innovate UK, the UK’s innovation agency, has awarded a significant grant of nearly £800,000 to a pioneering project, AI-VISION, aimed at advancing precision therapy in breast cancer treatment. This collaborative effort unites the expertise of cancer researchers from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, with cosmology and astrophysics specialists from the University of Durham, and…
Lunit, a South Korean company that recently secured $150M, has announced its plan to acquire Volpara Health Technologies, an AI-enabled software company specializing in the early detection and prevention of cancer. The acquisition, which is expected to be completed by the second quarter of 2024, involves Lunit acquiring all Volpara shares at AUD 1.15 per share, amounting to a deal worth approximately…
GE HealthCare has announced the release of MyBreastAI Suite, a new AI-powered platform for mammography, designed to aid clinicians in detecting breast cancer. This platform integrates AI applications from iCAD, focusing on breast density assessment and enhancing the efficiency of mammography workflows. Addressing the challenges posed by the global rise in breast cancer cases, MyBreastAI Suite aims to streamline breast cancer detection.…
